ISHARES TR's ticker is IBB and the CUSIP is 464287556. A total of 852 filers reported holding ISHARES TR in Q2 2022. The put-call ratio across all filers is 1.20 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,846,230 | -3.1% | 39,629 | +0.6% | 0.05% | -4.0% |
| Q2 2023 | $5,001,589 | -12.8% | 39,395 | -11.2% | 0.05% | -19.4% |
| Q1 2023 | $5,732,950 | -27.8% | 44,386 | -26.6% | 0.06% | -12.7% |
| Q4 2022 | $7,940,288 | -99.9% | 60,479 | -38.9% | 0.07% | +14.5% |
| Q3 2022 | $5,793,788,000 | +97553.6% | 98,978 | +96.2% | 0.06% | +1.6% |
| Q2 2022 | $5,933,000 | -9.2% | 50,438 | +0.6% | 0.06% | -10.3% |
| Q1 2022 | $6,531,000 | -13.6% | 50,123 | +1.2% | 0.07% | -11.7% |
| Q4 2021 | $7,559,000 | -19.7% | 49,527 | -15.0% | 0.08% | -18.1% |
| Q3 2021 | $9,417,000 | +11.7% | 58,242 | +13.1% | 0.09% | -2.1% |
| Q2 2021 | $8,431,000 | +9.5% | 51,516 | +0.7% | 0.10% | -2.0% |
| Q1 2021 | $7,702,000 | -26.0% | 51,154 | -25.1% | 0.10% | -19.0% |
| Q4 2020 | $10,409,000 | -99.8% | 68,266 | +35.8% | 0.12% | -4.7% |
| Q3 2020 | $6,808,000,000 | – | 50,275 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atom Investors LP | 78,501 | $10,139,189 | 5.52% |
| Bronte Capital Management Pty Ltd. | 302,076 | $39,016,136 | 4.53% |
| Michelson Medical Research Foundation, Inc. | 43,395 | $5,604,898 | 4.40% |
| Hackensack Meridian Health, Inc. | 228,000 | $29,448,480 | 4.26% |
| DAFNA Capital Management LLC | 102,500 | $13,238,900 | 3.97% |
| Richmond Brothers, Inc. | 16,724 | $2,159,856 | 3.64% |
| Alpha Family Trust | 34,549 | $4,462,349 | 3.53% |
| HANSEATIC MANAGEMENT SERVICES INC | 11,897 | $1,537 | 3.46% |
| PURSUE WEALTH PARTNERS LLC | 37,789 | $4,880,827 | 3.33% |
| Rye Brook Capital LLC | 40,100 | $5,179 | 3.17% |